Showing 1 - 10 results of 10 for search 'Michael J. Cork', query time: 0.05s Refine Results
  1. 1
    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial

    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin Accord... by Michael J. Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, Randy Prescilla

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1

    An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE... by Simon G. Danby, Paul V. Andrew, Kirsty Brown, John Chittock, Linda J. Kay, Michael J. Cork

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis

    Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis by Lisa A. Beck, Michael J. Cork, Masayuki Amagai, Anna De Benedetto, Kenji Kabashima, Jennifer D. Hamilton, Ana B. Rossi

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis

    Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis by Paul V. Andrew, Abigail Pinnock, Anna Poyner, Kirsty Brown, John Chittock, Linda J. Kay, Michael J. Cork, Simon G. Danby

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

    Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical tria... by Carsten Flohr, Michael J. Cork, Michael R. Ardern-Jones, Lawrence F. Eichenfield, Sébastien Barbarot, Claire Feeney, Ricardo Rojo, Irina Lazariciu, John Nesnas

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial

    Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomize... by Diala Alshiyab, Saleh A. Ba-shammakh, Abdulqudos Al-Fakih, Osama Tashman, Danyah Sarakbi, Firas Al-qarqaz, Jihan Muhaidat, Ausama Atwan, Michael J. Cork

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations

    Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations by Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years

    Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years by Elaine C. Siegfried, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Lara Wine Lee, Zhen Chen, Randy Prescilla, Ashish Bansal, Noah A. Levit, Ainara Rodríguez Marco

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis

    Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis by Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials

    Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials by Matthew P. Kosloski, Emma Guttman‐Yassky, Michael J. Cork, Margitta Worm, Dong‐Ho Nahm, Xiaoping Zhu, Marcella K. Ruddy, Sivan Harel, Mohamed A. Kamal, Hélène Goulaouic, Christine R. Xu, Elena Avetisova, John D. Davis, Michael C. Nivens, Arsalan Shabbir, Allen Radin

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: